Benchmark raised the firm’s price target on Dave (DAVE) to $119 from $95 and keeps a Buy rating on the shares. Shares have increased in value by 1,009% year-to-date, so it might “simply make sense for investors to ask at this point whether they had missed the trade on the name.” However, the firm believes Dave’s growth prospects are not fully reflected in the current valuations, especially since “such prospects have improved significantly” and the firm views Dave as “well positioned to drive additional gains” by sustaining operating momentum.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio